Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
about
Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaA systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problemsPharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.Sustained-release naltrexone: novel treatment for opioid dependence.Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.Pharmacological enhancement of naltrexone treatment for opioid dependence: a reviewEmployment-based reinforcement of adherence to oral naltrexone in unemployed injection drug users: 12-month outcomesDesign and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial.Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.Maintenance of reinforcement to address the chronic nature of drug addiction.Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.The Effects of Family-Centered Problem-Solving Education on Relapse Rate, Self Efficacy and Self Esteem Among Substance AbusersRole of Benzodiazepines in the management of agitation due to inappropriate use of naltrexone.A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence.The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.Animal models for opioid addiction drug discovery.Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.Possible role of a dysregulation of the endogenous opioid system in antisocial personality disorder.Retention in medication-assisted treatment for opiate dependence: A systematic review.The Role of Sexual Behaviors in the Relapse Process in Iranian Methamphetamine Users: A Qualitative Study.Economic Evaluations of Opioid Use Disorder Interventions.Acute Myocardial Infarction following Naltrexone Consumption; a Case Report.Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
P2860
Q26778626-A35A029B-9A51-4AF0-BD06-234A725F1B04Q28072735-8321D9C6-747F-41E9-AF94-56C146C85F45Q33582063-FCBFFA4A-5C9A-4DA2-A80C-192DC0C48C5AQ33595868-275F1C7F-3772-4D3C-9815-DFD6282851F8Q34660956-4C3DD0A8-378F-469E-A3E6-7A54FCCA6B8EQ35023989-7A0C0771-84FA-40C8-BFF3-5108189982D2Q35084340-70BBB6BD-4B36-47C0-B014-7106090D9354Q35118798-11F61EFA-D510-477D-B239-F1D5B476CDDCQ35220086-44F7737A-D411-4B34-942E-62FADA456D58Q35633106-5212A11D-5872-476B-80D4-82AB1561AD89Q35833732-B7CE8296-28EC-4289-AD5C-1C6E4F2FFA40Q36218625-D774E938-867E-419F-B15F-DAB0EEC13C5BQ36808909-85C11305-806B-4613-A048-48E822A23904Q36879657-B9146B16-82ED-427B-9011-6C9BB2E05FFBQ36987496-5DE37022-BBAF-466A-9B7B-9BF1FD8A9DBFQ37570243-2D149AF1-9B17-4A39-A5FF-06923FC6E4EDQ37663311-7E466642-5D67-441A-84E4-1A55ABC82A93Q38167693-6584C1C5-592A-40ED-80EC-F31A68426ACBQ38259272-14E3F172-2AD6-4401-8A31-53DD4AD96E85Q38373652-A591F475-EC1E-41B9-8ED1-8D8CBE9D6A66Q38562081-88B53D60-AA4A-4457-89AE-F7DBBCA3B6ABQ38607448-64810BBD-8CD1-49DB-8FC7-19B612DD499EQ38618951-AACD994E-A022-4AB5-A597-51B57A639B51Q38784603-990C1C00-09FD-4C15-8A61-1E32257C9016Q42183983-AD83805E-AFDD-4B45-B882-5DBA8F4AD5B2Q44344147-11EB6E39-9556-4363-9AB9-46E35D3EB971
P2860
Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Oral naltrexone as a treatment ...... eview and economic evaluation.
@ast
Oral naltrexone as a treatment ...... eview and economic evaluation.
@en
Oral naltrexone as a treatment ...... eview and economic evaluation.
@nl
type
label
Oral naltrexone as a treatment ...... eview and economic evaluation.
@ast
Oral naltrexone as a treatment ...... eview and economic evaluation.
@en
Oral naltrexone as a treatment ...... eview and economic evaluation.
@nl
prefLabel
Oral naltrexone as a treatment ...... eview and economic evaluation.
@ast
Oral naltrexone as a treatment ...... eview and economic evaluation.
@en
Oral naltrexone as a treatment ...... eview and economic evaluation.
@nl
P2093
P356
P1476
Oral naltrexone as a treatment ...... eview and economic evaluation.
@en
P2093
Juarez-Garcia A
P304
iii-iv, 1-85
P356
10.3310/HTA11060
P577
2007-02-01T00:00:00Z